Compare IRMD & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRMD | PGNY |
|---|---|---|
| Founded | 1992 | 2008 |
| Country | United States | United States |
| Employees | N/A | 856 |
| Industry | Medical/Dental Instruments | Misc Health and Biotechnology Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2014 | 2019 |
| Metric | IRMD | PGNY |
|---|---|---|
| Price | $88.67 | $17.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 10 |
| Target Price | ★ $116.00 | $26.50 |
| AVG Volume (30 Days) | 78.2K | ★ 1.1M |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | ★ 0.89% | N/A |
| EPS Growth | ★ 16.67 | 14.04 |
| EPS | ★ 1.75 | 0.65 |
| Revenue | $83,814,000.00 | ★ $1,288,661,000.00 |
| Revenue This Year | $12.38 | $8.87 |
| Revenue Next Year | $11.31 | $9.76 |
| P/E Ratio | $51.58 | ★ $27.78 |
| Revenue Growth | ★ 14.43 | 10.40 |
| 52 Week Low | $50.36 | $16.10 |
| 52 Week High | $107.90 | $28.75 |
| Indicator | IRMD | PGNY |
|---|---|---|
| Relative Strength Index (RSI) | 33.95 | 47.64 |
| Support Level | $82.64 | $16.88 |
| Resistance Level | $105.87 | $18.60 |
| Average True Range (ATR) | 2.73 | 0.62 |
| MACD | -0.45 | 0.21 |
| Stochastic Oscillator | 0.00 | 52.08 |
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.